Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation

August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents

ANN ARBOR, MI / ACCESS Newswire / August 11, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, August 28, 2026, at 4:00 p.m. Eastern Time.

The August program, titled "Fourth Friday at Four - Zomedica International: Building a Global Platform for Veterinary Innovation," will offer current and prospective investors a comprehensive look at Zomedica's international commercial strategy, the distributor infrastructure that supports it, the global market opportunity that drives it, and the leadership team executing it. The session will trace the arc of Zomedica's international expansion from its earliest market entries through the disciplined, phased build-out of a global distribution architecture now spanning active commercial operations across Europe, Asia-Pacific, the Middle East, and the Americas, with additional markets in active negotiation.

The session is built around a central idea: international growth at Zomedica is real, growing, and increasingly organic. The company has invested in distribution partnerships, regulatory readiness, clinical support infrastructure, and dedicated leadership required to build a scalable, asset-light commercial operation outside North America.

Larry Heaton, Chief Executive Officer of Zomedica, commented, "International expansion has been a deliberate, phased, and disciplined priority for Zomedica, and we are now at a stage where the infrastructure we have built is producing real commercial results. We have established distribution partnerships with credible, established partners across multiple continents, secured the regulatory milestones necessary to bring our full product portfolio into new geographies, and put dedicated leadership in place to drive execution in every market we serve. This webinar is an opportunity for investors to see the full scope of that strategy, to understand the size and trajectory of the international opportunity, and to hear directly from the people who are making it happen."

The session will connect Zomedica's international strategy to the company's Five Pillars framework and broader investor thesis. It will demonstrate how the same multi-product platform approach that drives domestic growth, spanning diagnostics with the VETGuardian®, TRUFORMA® and TRUVIEW® platforms and therapeutic devices with the PulseVet®, Assisi Loop®, EquiLoop®, VETIGEL® product lines, translates directly into international markets through established distribution partnerships and targeted clinical support. It will show how the company's land-and-expand strategy is being replicated internationally, how regulatory milestones unlock portfolio expansion within existing partner territories, and how the recurring revenue model built in the domestic business is being applied globally through an asset-light distribution infrastructure.

Webinar Details

Title: "Fourth Friday at Four - Zomedica International: Building a Global Platform for Veterinary Innovation"

Date/Time: Friday, August 28, 2026, at 4:00 p.m. Eastern Time

Registration: https://itl.ink/FourthFridayAugust

Format: Customer testimonials, prepared remarks, featured interviews with Zomedica's international commercial and clinical leadership, and a live Question & Answer session

Don't miss your chance to connect with Zomedica's international commercial leadership, gain insight into the company's expanding global distribution network, and explore what's next in Zomedica's international growth strategy. Whether you're a veterinary professional, industry partner, investor, or simply passionate about helping our pets live healthier lives, this series is for you.

About Zomedica

Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians with innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi Loop® line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW® digital cytology system, the VETGuardian PLUSTM Zero Touch® monitoring system and VETIGEL® hemostatic gel, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. Zomedica grew revenue 17% in 2025 to $32 million, 36% through the six months ended June 30, 2026 to $18 million, and maintains a strong balance sheet with approximately $44 million in liquidity as of June 30, 2026. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit www.zomedica.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica
• Facebook: https://m.facebook.com/zomedica
• X (formerly Twitter): https://twitter.com/zomedica
• Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact

Zomedica Investor Relations [email protected] 1-734-369-2555; Option #5

SOURCE: Zomedica Corp.

View the original

press release

on ACCESS Newswire